Fluidx Medical Technology announces results of its GPX-Clear Embolic Device in-vivo research which uses the base GPX technology and incorporates an intermediate term radiopacity agent. "Our initial in-vivo work with GPX-Clear looks very promising. It has the advantages of the baseline GPX product around ease of use, minimal preparation and compatibility with standard microcatheters, with the added benefit of radiopacity that dissipates within the first 24 hours," said Ryan

The ABHI UK Pavilion at Arab Health 2022 united a former NASA astronaut and world-leading surgeon to journey into the future of healthcare with Space and 3D technologies. The expert panel discussion took place at The Arab Health Exhibition & Congress, the leading healthcare exhibition in the Middle East, exploring the lessons that can be learnt from working in space, recent advancements in 3D Printing and the importance of continuing to innovate to take one giant leap forward fo

The UK Government welcomed a panel of esteemed UK and UAE experts in its digital health at Arab Health 2022 – the leading healthcare exhibition in the Middle East – to explore the role digital health has in improving patient outcomes in the UK and the Middle East. The seminar, ‘Next Steps for Digital Health’, featured Dr Mubaraka Ibrahim, NHS Transformation representative Dr Tim Ferris, Babylon CEO Ali Parsa, Dr Dirk Richter, and Neville Young, Director of En

Hugel America, Inc., a growth-focused joint venture between aesthetic market-leading partners Hugel Inc., and Croma-Pharma GmbH (Croma), announced that Croma has completed the decentralized procedure in Europe for Letybo® (LetibotulinumtoxinA for Injection) to treat glabellar (frown) lines. The Letybo® submission in Europe is based on the data of three completed randomized, placebo-controlled phase III trials that enrolled more than 1000 subjects in the US and Europe. Nation

Kareo, the leading provider of cloud-based clinical and business management software solutions for independent healthcare practices and billing companies, today announced that its client, The Weichman Clinic, a highly sought-after provider for comprehensive mental health services for children in Newport Beach, California, has expanded its use of Kareo’s integrated platform. The Weichman Clinic has adopted Kareo Telehealth to see and treat patients remotely while also providing continuit

The union representing most Ontario paramedics is calling on the provincial government to address mental health of emergency medical services staff amidst gruelling working conditions through the pandemic. “Paramedics and dispatchers have struggled with heavy workloads for years. But the sharp increase in call volumes and lengthier offload delays at hospitals during the pandemic has worsened working conditions. Paramedics and dispatchers are burning out and desperately require

HCA Healthcare, Inc.  one of the nation’s leading healthcare providers, today announced plans to build five new full-service hospitals in Texas to help meet the state’s growing need for healthcare services. The new hospitals will be located in the following locations across the state: One new full-service hospital in the Dallas Fort-Worth area One new full-service hospital in the Houston area One new full-service hospital in t

CoagCo LLC, a Cleveland-based medical device company, announced today that it has entered into a national distribution agreement with North American Rescue LLC, a manufacturer and supplier of life-saving medical and rescue solutions for the military, federal agencies, law enforcement, and first responders. NAR will distribute CoagCo’s proprietary nosebleed device, Coag it NP7®, a nasal packing device designed for painless insertion by secondary providers for nosebleeds in

ENDRA Life Sciences Inc., a pioneer of enhanced ultrasound technologies, today announced it has received Institutional Review Board approval from China’s renowned Shanghai General Hospital (Shanghai First People’s Hospital Affiliated with Shanghai Jiao Tong University), for the first clinical study of ENDRA’s Thermo Acoustic Enhanced UltraSound (TAEUS®) device to assess Non-Alcoholic Fatty Liver Disease (NAFLD) in that market. “ENDRA is honored to bring o

Ipsen today announced the Health Canada approval of Sohonos (palovarotene capsules), an oral selective retinoic-acid receptor gamma (RARγ) agonist indicated to reduce the formation of heterotopic ossification (HO; new bone formation) in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva (FOP).1 Sohonos is approved for the treatment of patients with FOP for both chronic use, and for flare-ups, in these patien